Deal facts
- Buyer
- GSK plc
- Target
- 35Pharma Inc.
- Deal value
- USD 950,000,000
- Announced
- 15 April 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- Canada
- Consideration
- cash
Sources
GSK plc has agreed to acquire 35Pharma Inc., a Canadian biopharmaceutical company, for an equity value of USD 950 million. The transaction was structured as a strategic acquisition with full cash consideration. Both the announcement and completion of the deal occurred on 15 April 2026, indicating an immediate closing without a prolonged regulatory waiting period. This acquisition represents a significant capital deployment into the biopharmaceutical sector by the buyer.
The deal was finalised on the same day it was announced, suggesting a streamlined approval process or prior regulatory clearance. No specific details regarding the target's revenue or the specific assets acquired were reported in the available data. The transaction is now complete, with GSK plc having taken full ownership of the Canadian entity. The parties have concluded all necessary legal and financial obligations required to transfer control of the business.
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- CompletedClosed
GSK plc to acquire 35Pharma Inc.
{ "headline": "GSK completes acquisition of 35Pharma Inc.", "issuer": "GSK (GSK)", "announcement_date": "2026-04-15T07:12:00", "category_code": "Completion of Acquisition", "body": "Disclaimer* \n\n Issued: 15 April 2026, London UK \n\n \n\n GSK completes acquisition of 35Pharma Inc. \n\n \n\n \n\n \n\n GSK plc (LSE/NYSE: GSK) today announced the completion of its acquisition of
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Shuttle Pharmaceuticals Holdings, Inc. to acquire United Dogecoin Inc.
Shuttle Pharmaceuticals Holdings, Inc. and United Dogecoin Inc. entered the Exit Mode archive.
- Buyer
- Shuttle Pharmaceuticals Holdings, Inc.
- Target
- United Dogecoin Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
MedPal AI plc to acquire Remedi Solutions Limited
MedPal AI plc and Remedi Solutions Limited entered the Exit Mode archive.
- Buyer
- MedPal AI plc
- Target
- Remedi Solutions Limited
- Deal value
- GBP 310,000
- Deal type
- strategic acquisition
BIOMARIN PHARMACEUTICAL INC to acquire Amicus
BIOMARIN PHARMACEUTICAL INC and Amicus entered the Exit Mode archive.
- Buyer
- BIOMARIN PHARMACEUTICAL INC
- Target
- Amicus
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Telomir Pharmaceuticals, Inc. to acquire TELI Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. and TELI Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Telomir Pharmaceuticals, Inc.
- Target
- TELI Pharmaceuticals, Inc.
- Deal value
- USD 34,389,710
- Deal type
- strategic acquisition
EKF Diagnostics Holdings plc to acquire Beep Insights AB
EKF Diagnostics Holdings plc has agreed to acquire Beep Insights AB, a Swedish company operating within the diagnostics sector. The transaction is structured as a strate…
- Buyer
- EKF Diagnostics Holdings plc
- Target
- Beep Insights AB
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
GSK plc
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive